Cardlytics, Inc. operates a purchase intelligence platform in the United States and the United Kingdom. It operates in two segments, Cardlytics Direct and Other Platform Solutions. The company's platform is the Cardlytics Direct solution, a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. It also provides solutions that enable marketers and marketing service providers to leverage the power of purchase intelligence outside the banking channel. The company was founded in 2008 and is headquartered in Atlanta, Georgia.
Industry, Sector and Symbol
Industry Computer programming, data processing, & other computer related
Sub-IndustryN/A
SectorBusiness Services
SymbolNASDAQ:CDLX
CUSIPN/A
Phone888-798-5802
Debt
Debt-to-Equity Ratio0.81
Current Ratio1.68
Quick Ratio1.68
Price-To-Earnings
Trailing P/E Ratio-3.05
Forward P/E Ratio-12.41
P/E GrowthN/A
Sales & Book Value
Annual Sales$130.37 million
Price / Sales3.80
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
Employees342
Outstanding Shares20,260,000
Cardlytics (NASDAQ:CDLX) Frequently Asked Questions
What is Cardlytics' stock symbol?
Cardlytics trades on the NASDAQ under the ticker symbol "CDLX."
How were Cardlytics' earnings last quarter?
Cardlytics Inc (NASDAQ:CDLX) posted its quarterly earnings data on Thursday, May, 10th. The company reported ($0.60) earnings per share for the quarter, topping the Zacks' consensus estimate of ($0.62) by $0.02. The company had revenue of $32.71 million for the quarter, compared to analysts' expectations of $29.74 million. View Cardlytics' Earnings History.
What price target have analysts set for CDLX?
6 brokerages have issued 12 month target prices for Cardlytics' stock. Their forecasts range from $19.00 to $25.00. On average, they anticipate Cardlytics' stock price to reach $22.40 in the next year. View Analyst Ratings for Cardlytics.
Who are some of Cardlytics' key competitors?
Some companies that are related to Cardlytics include Jianpu Technology (JT), TrueCar (TRUE), Internet Initiative Japan (IIJI), 21Vianet Group (VNET), HealthStream (HSTM), Model N (MODN), Internap (INAP), The Rubicon Project (RUBI), Edgewater Technology (EDGW), Sify Technologies (SIFY), Synacor (SYNC), Autoweb (AUTO), Chinanet Online (CNET), MassRoots (MSRT) and GigaMedia (GIGM).
Who are Cardlytics' key executives?
Cardlytics' management team includes the folowing people:
- Mr. Scott D. Grimes, Co-Founder, CEO & Director (Age 55)
- Ms. Lynne Marie Laube, Co-Founder, COO & Director (Age 49)
- Mr. David Evans, CFO & Head of Corp. Devel.
- Mr. Sathish Gaddipati, Chief Technology Officer (Age 51)
- Mr. Kirk L. Somers, Chief Legal & Privacy Officer (Age 53)
When did Cardlytics IPO?
(CDLX) raised $76 million in an IPO on Friday, February 9th 2018. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan served as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers.
When does Cardlytics' lock-up period expire?
Cardlytics' lock-up period expires on Wednesday, August 8th. Cardlytics had issued 5,400,000 shares in its public offering on February 9th. The total size of the offering was $70,200,000 based on an initial share price of $13.00. After the expiration of Cardlytics' lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company will be lifted.
Has Cardlytics been receiving favorable news coverage?
News headlines about CDLX stock have been trending somewhat positive recently, according to Accern Sentiment Analysis. The research group scores the sentiment of media coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Cardlytics earned a coverage optimism score of 0.15 on Accern's scale. They also assigned headlines about the company an impact score of 46.24 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the near future.
Who are Cardlytics' major shareholders?
Cardlytics' stock is owned by many different of retail and institutional investors. Top institutional shareholders include Polaris Venture Management Co. V L.L.C. (13.18%), Federated Investors Inc. PA (2.00%), BlackRock Inc. (1.17%), Millennium Management LLC (0.87%), Citadel Advisors LLC (0.53%) and Kornitzer Capital Management Inc. KS (0.31%). Company insiders that own Cardlytics stock include David Thomas Evans and Scott D Grimes. View Institutional Ownership Trends for Cardlytics.
Which institutional investors are buying Cardlytics stock?
CDLX stock was bought by a variety of institutional investors in the last quarter, including Polaris Venture Management Co. V L.L.C., Federated Investors Inc. PA, BlackRock Inc., Millennium Management LLC, Citadel Advisors LLC, Kornitzer Capital Management Inc. KS, Northern Trust Corp and Penn Capital Management Co. Inc.. Company insiders that have bought Cardlytics stock in the last two years include David Thomas Evans and Scott D Grimes. View Insider Buying and Selling for Cardlytics.
How do I buy shares of Cardlytics?
Shares of CDLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Cardlytics' stock price today?
One share of CDLX stock can currently be purchased for approximately $24.45.
How big of a company is Cardlytics?
Cardlytics has a market capitalization of $495.26 million and generates $130.37 million in revenue each year. The company earns $-19,640,000.00 in net income (profit) each year or ($8.02) on an earnings per share basis. Cardlytics employs 342 workers across the globe.
How can I contact Cardlytics?
Cardlytics' mailing address is 675 PONCE DE LEON AVENUE NE SUITE 6000, ATLANTA GA, 30308. The company can be reached via phone at 888-798-5802 or via email at [email protected]
MarketBeat Community Rating for Cardlytics (CDLX)
MarketBeat's community ratings are surveys of what our community members think about Cardlytics and other stocks. Vote "Outperform" if you believe CDLX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CDLX will underperform the S&P 500 over the long term. You may vote once every thirty days.
